Your shopping cart is currently empty

Conopeptide rho-TIA, a peptide from Conus tulipa venom, acts as a selective, noncompetitive inhibitor at the human α1B-Adrenergic Receptor and as a competitive inhibitor at the α1A and α1D-Adrenergic Receptors. Binding to these subtypes, conopeptide rho-TIA may inform the creation of new α1-Adrenergic Receptor subtype-selective drugs [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Conopeptide rho-TIA, a peptide from Conus tulipa venom, acts as a selective, noncompetitive inhibitor at the human α1B-Adrenergic Receptor and as a competitive inhibitor at the α1A and α1D-Adrenergic Receptors. Binding to these subtypes, conopeptide rho-TIA may inform the creation of new α1-Adrenergic Receptor subtype-selective drugs [1]. |
| In vitro | Conopeptide rho-TIA at a concentration of 100 nM applied for 24-48 hours interacts with human α1B-Adrenergic Receptor non-competitively and reversibly, suggesting its potential role as an allosteric inhibitor [1]. At 30 nM for 2 hours, conopeptide rho-TIA acts as a non-competitive inhibitor for the α1B-Adrenergic Receptor but competitively inhibits the α1A and α1D-Adrenergic Receptor subtypes [1]. Additionally, a single application of 10 μM conopeptide rho-TIA inhibits the increase in cytoplasmic Ca2+ concentration mediated by the α1-Adrenergic Receptor activation by norepinephrine, without affecting the presynaptic α2-Adrenergic Receptor-mediated responses [2]. |
| Molecular Weight | 2390.88 |
| Formula | C105H160N36O21S4 |
| Cas No. | 381725-58-2 |
| Smiles | C([C@@H](C(N[C@H](C(N[C@@H]1C(=O)N[C@@]2(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@]([C@H](CC)C)(C(=O)N3[C@](C(=O)N[C@@H](C)C(=O)N[C@@](CSSC1)(C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@H](C(N)=O)CSSC2)[H])(CCC3)[H])[H])[H])=O)CCCNC(=N)N)=O)NC([C@@H](NC([C@H](CC6=CC=CC=C6)N)=O)CC(N)=O)=O)C=7C=8C(NC7)=CC=CC8 |
| Sequence | Phe-Asn-Trp-Arg-Cys-Cys-Leu-Ile-Pro-Ala-Cys-Arg-Arg-Asn-His-Lys-Lys-Phe-Cys-NH2 (Disulfide bridge: Cys5-Cys11, Cys6-Cys19) |
| Sequence Short | FNWRCCLIPACRRNHKKFC (Disulfide bridge: Cys5-Cys11, Cys6-Cys19) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.